1076232-78-4 Usage
Uses
Used in Organic Synthesis:
[3-(4-Chloro-1H-benzothiazol-2-yl)phenyl]boronic acid is used as a building block in organic synthesis for the creation of various complex molecules and compounds.
Used in Medicinal Chemistry:
In the field of medicinal chemistry, [3-(4-Chloro-1H-benzothiazol-2-yl)phenyl]boronic acid serves as a key intermediate, playing a crucial role in the development of new pharmaceutical products.
Used in Pharmaceutical Industry:
[3-(4-Chloro-1H-benzothiazol-2-yl)phenyl]boronic acid is utilized in the pharmaceutical industry as a component in the production of various drugs, contributing to the advancement of medical treatments.
Used in Agrochemical Industry:
[3-(4-Chloro-1H-benzothiazol-2-yl)phenyl]boronic acid is also employed in the agrochemical industry, where it acts as a vital intermediate in the synthesis of agricultural products, such as pesticides and fertilizers.
Used in Cancer Treatment Research:
[3-(4-Chloro-1H-benzothiazol-2-yl)phenyl]boronic acid has shown potential in the treatment of various diseases, particularly cancer. It has demonstrated promising results in inhibiting the growth of cancer cells in laboratory studies, making it a compound of interest for further research and development in the field of medicine.
Check Digit Verification of cas no
The CAS Registry Mumber 1076232-78-4 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,7,6,2,3 and 2 respectively; the second part has 2 digits, 7 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 1076232-78:
(9*1)+(8*0)+(7*7)+(6*6)+(5*2)+(4*3)+(3*2)+(2*7)+(1*8)=144
144 % 10 = 4
So 1076232-78-4 is a valid CAS Registry Number.
1076232-78-4Relevant academic research and scientific papers
Novel compounds useful for bradykinin B1 receptor antagonism
-
Page/Page column 35-36, (2010/11/25)
Disclosed are compounds that are bradykinin B1 receptor antagonists and are useful for treating diseases, or relieving adverse symptoms associated with disease conditions, in mammals mediated by bradykinin B1 receptor.
